Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Phosphatidylcholine Biosynthesis Pathway encompasses the enzymatic reactions responsible for synthesizing phosphatidylcholine (PC), a major phospholipid component of eukaryotic cell membranes. Two primary routes exist: the CDP-Choline (Kennedy) pathway and the Phosphatidylethanolamine Methylation pathway. Key enzymes include choline kinase, CTP:phosphocholine cytidylyltransferase, and cholinephosphotransferase. PC plays essential roles in membrane structure, signaling, and as a biosynthetic intermediate. Targeting this pathway has implications for various diseases, including liver disease, neurodegenerative disease, and cancer.
Modulation of enzyme activity in phosphatidylcholine synthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylcholine Biosynthesis Pathway (None).